(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|
Turnover | 26.39%342.37M | 16.27%1.33B | --270.89M | -22.01%1.15B | 35.05%1.47B | --1.09B |
Operating income | 26.39%342.37M | 16.27%1.33B | 270.89M | -22.01%1.15B | 35.05%1.47B | 1.09B |
Cost of sales | -22.79%-271.83M | -14.71%-1.05B | ---221.37M | 22.14%-918.65M | -38.40%-1.18B | ---852.49M |
Operating expenses | -22.79%-271.83M | -14.71%-1.05B | -221.37M | 22.14%-918.65M | -38.40%-1.18B | -852.49M |
Gross profit | 42.45%70.54M | 22.57%280.25M | 49.52M | -21.48%228.64M | 23.00%291.18M | 236.72M |
Selling expenses | 21.56%-27.44M | 5.73%-139.07M | ---34.99M | 23.57%-147.52M | -82.50%-193.02M | ---105.76M |
Administrative expenses | 2.44%-30.82M | -22.17%-135.82M | ---31.59M | 6.99%-111.18M | -57.78%-119.53M | ---75.75M |
Research and development expenses | -19.80%-33.59M | 0.54%-128.03M | ---28.04M | 10.21%-128.73M | -49.26%-143.36M | ---96.05M |
Revaluation surplus | -126.74%-120.39M | -298.44%-210.77M | ---53.1M | 10.69%-52.9M | -144.30%-59.23M | --133.7M |
-Changes in the fair value of financial assets | -310.30%-8.86M | -276.90%-54.68M | --4.22M | -16.99%30.91M | -72.15%37.24M | --133.7M |
-Changes in the fair value of other assets | -94.60%-111.53M | -86.24%-156.09M | ---57.31M | 13.12%-83.81M | ---96.47M | ---- |
Impairment and provision | -132.22%-4.4M | -42.80%-11.76M | ---1.89M | -72.85%-8.23M | -12,434.21%-4.76M | ---38K |
-Other impairment is provision | -132.22%-4.4M | -42.80%-11.76M | ---1.89M | -72.85%-8.23M | -12,434.21%-4.76M | ---38K |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---16.53M |
Special items of operating profit | -94.31%226K | 83.93%29.26M | --3.97M | 5.65%15.91M | -34.66%15.06M | --23.04M |
Operating profit | -51.77%-145.87M | -54.87%-315.95M | -96.11M | 4.52%-204.01M | -315.10%-213.66M | 99.33M |
Financing cost | 2.93%-2.15M | 6.68%-8.16M | ---2.22M | -44.66%-8.75M | ---6.05M | ---- |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | --76K |
Earning before tax | -50.54%-148.02M | -52.34%-324.11M | -98.33M | 3.17%-212.75M | -321.02%-219.71M | 99.41M |
After-tax profit from continuing operations | -50.54%-148.02M | -52.34%-324.11M | -98.33M | 3.17%-212.75M | -321.02%-219.71M | 99.41M |
Earning after tax | -50.54%-148.02M | -52.34%-324.11M | -98.33M | 3.17%-212.75M | -321.02%-219.71M | 99.41M |
Profit attributable to shareholders | -50.54%-148.02M | -52.34%-324.11M | -98.33M | 3.17%-212.75M | -321.02%-219.71M | 99.41M |
Basic earnings per share | -50.50%-3.04 | -52.40%-6.66 | -2.02 | 3.32%-4.37 | -4.52 | |
Diluted earnings per share | -50.50%-3.04 | -52.40%-6.66 | -2.02 | 3.32%-4.37 | -4.52 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data